Funding

2017 CancerCare Manitoba Foundation Research Operating Grants

  • 16 grants submitted, 8 funded
  • 50% success rate
  • Total $ of awarded grants: $458,347
  • Total $ of operating grants: $1,095,290
  • Average score: 4.13

Grants awarded to:

  • Naseer Ahmed “Identification of cancer specific metabolic signatures in body fluids of the patients with early stage lung cancer using proton magnetic resonance spectroscopy (MRS) and mass spectrometry (MS)”
  • David Dawe “Treatment, Outcomes, and Costs for Metastatic Non-Small Cell Lung Cancer in Manitoba”
  • Davinder Jassal “Flaxseed in the mitigation of anthracycline and trastuzumab mediated cardiotoxicity (FANTAM) study”
  • Kirk McManus “Identifying and Characterizing the Pathogenic Origins of Colorectal Cancer.”
  • Yvonne Myal “Delineating the immune regulatory role of prolactin inducible protein (PIP) in breast cancer”
  • Marshall Pitz/Harminder Singh ”Developing algorithms to accurately and efficiently identify breast and colorectal cancer recurrence”
  • Wayne Xu “Retrospective study of the 10-gene yin yang expression ratio signature for early stage lung cancer”
  • Ryan Zarychanski “Heparin anticoagulation to improve outcomes in septic shock: The HALO International Phase II Trial”

Scientific Advisory Committee Members:

  • Depeng Jiang
  • Richard Keijzer
  • Soheila Karimi
  • Ji Hyun Ko
  • Melanie Martin
  • Mojgan  Rastegar
  • Louise Simard
  • Geert  t’Jong
  • Shayne Taback
  • Mahmoud Torabi
  • Jeffrey Wigle

Calendar of Research Funding Opportunities